Access cutting-edge dry eye disease treatment through this clinical trial at a research site in Shelby. Study-provided care at no cost to qualified participants.
Access dry eye disease specialists in Shelby at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dry eye disease treatment provided free
The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness. Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness. Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.
Sponsor: BioTissue Holdings, Inc
Check if you qualify for this dry eye disease clinical trial in Shelby, NC
If you're searching for dry eye disease treatment options in Shelby, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Shelby research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry eye disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.